- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 9, 2024 | 40.95M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $262.83M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $269.07M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $4.02M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $5.42M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $7.02M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $8.63M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $265.6M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $272.45M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $270.52M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $277.71M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 39.44M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $0 |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$6.68M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $282.67M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $289.07M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | $0.23 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | $0.23 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $5.25M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $6.74M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$9.09M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$11.99M |